NEUROTHERA LABS, INC.

Lobbying client · Ontario · filed 2026 to 2026

Pharmaceutical company

$10,000 Reported spend

2 Filings counted

1 Outside firm hired

0 Bills named

Spend is reported income plus in-house expenses across 2 filings. Everything on this page comes from one LDA client record (75210), filed by the registrant listed below.

Who filed for this client 1

RK STRATEGIES, INC. $10,000 Outside firm · 2 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Reported by year 1 year

2026 $10,000 2 filings

Issues lobbied 1

Health Issues 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 1
SENATE 1

Recent filings 2 total

Q3 report

RK STRATEGIES, INC.

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $10,000 income · posted Oct 20, 2026

View → Registration

RK STRATEGIES, INC.

3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 2, 2026

View →

Foreign entities disclosed 1

SCISPARC LTD. Israel named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $10,000

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Keep going

Filings through October 20, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.